Literature DB >> 11397159

Solution and solid-support synthesis of a potential leishmaniasis carbohydrate vaccine.

M C Hewitt1, P H Seeberger.   

Abstract

The synthesis of a potential carbohydrate vaccine for the parasitic disease leishmaniasis is described. New solution- and solid-phase synthetic strategies were explored for the assembly of a unique tetrasaccharide antigen found on the Leishmania lipophosphoglycan. An initial solution-phase synthesis relied on thioglycosides as building blocks and the establishment of the central disaccharide from lactal via an oxidation-reduction sequence. A second approach was completed both in solution and on solid support. The solid-phase synthesis relied on assembly from monosaccharide units and was used to evaluate different glycosylating agents in the efficient installation of the galactose beta-(1-->4) mannoside. Glycosyl phosphates proved most successful in this endeavor. This first solid-phase synthesis of the Leishmania cap provided rapid access to the tetrasaccharide in 18% overall yield while requiring only a single purification step. The synthetic cap tetrasaccharide was conjugated to the immunostimulator Pam3Cys to create fully synthetic carbohydrate vaccine 1 and to the carrier protein KLH to form semisynthetic vaccine 2. Currently, both constructs have entered initial immunological experiments in mice targeted at the development of a vaccine against the parasitic disease leishmaniasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11397159     DOI: 10.1021/jo015521z

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  10 in total

1.  AuBr(3) mediated glycosidations: synthesis of tetrasaccharide motif of the Leishmania donovani lipophosphoglycan.

Authors:  Gopalsamy Sureshkumar; Srinivas Hotha
Journal:  Glycoconj J       Date:  2012-06-03       Impact factor: 2.916

Review 2.  Carbohydrate vaccines: developing sweet solutions to sticky situations?

Authors:  Rena D Astronomo; Dennis R Burton
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

3.  A fluorous phosphate protecting group with applications to carbohydrate synthesis.

Authors:  Lin Liu; Nicola L B Pohl
Journal:  Org Lett       Date:  2011-03-08       Impact factor: 6.005

Review 4.  Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines.

Authors:  A V Nikolaev; O V Sizova
Journal:  Biochemistry (Mosc)       Date:  2011-07       Impact factor: 2.487

5.  Synthesis of multivalent tuberculosis and Leishmania-associated capping carbohydrates reveals structure-dependent responses allowing immune evasion.

Authors:  Eun-Ho Song; Alex O Osanya; Christine A Petersen; Nicola L B Pohl
Journal:  J Am Chem Soc       Date:  2010-08-25       Impact factor: 15.419

Review 6.  Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?

Authors:  Claire-Lise Forestier; Qi Gao; Geert-Jan Boons
Journal:  Front Cell Infect Microbiol       Date:  2015-01-21       Impact factor: 5.293

Review 7.  Synthetic Glycobiology: Parts, Systems, and Applications.

Authors:  Weston Kightlinger; Katherine F Warfel; Matthew P DeLisa; Michael C Jewett
Journal:  ACS Synth Biol       Date:  2020-06-30       Impact factor: 5.110

8.  Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans.

Authors:  Felix Broecker; Jonas Hanske; Christopher E Martin; Ju Yuel Baek; Annette Wahlbrink; Felix Wojcik; Laura Hartmann; Christoph Rademacher; Chakkumkal Anish; Peter H Seeberger
Journal:  Nat Commun       Date:  2016-04-19       Impact factor: 14.919

9.  Acyclic Sesquiterpenes from the Fruit Pericarp of Sapindus saponaria Induce Ultrastructural Alterations and Cell Death in Leishmania amazonensis.

Authors:  Amanda Louzano Moreira; Débora Botura Scariot; Bruna Luíza Pelegrini; Greisiele Lorena Pessini; Tânia Ueda-Nakamura; Celso Vataru Nakamura; Izabel Cristina Piloto Ferreira
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-22       Impact factor: 2.629

Review 10.  Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines.

Authors:  Qingjiang Li; Zhongwu Guo
Journal:  Molecules       Date:  2018-06-29       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.